DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/20d8bb/coagulation_disord) has announced the addition of the "Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline" report to their offering.
Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline, provides in-depth analysis of unmet needs, drivers and barriers that impact the global coagulation disorders market. The report analyzes the markets for coagulation disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.
Market size, annual cost of therapy and treatment usage patterns are forecast until 2017 for the key geographies, as well as the leading therapeutic segments which includes hemophilia A, hemophilia B and von Willebrand Disease. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global coagulation disorders market.
The analysis indicates that the global coagulation disorders market has been one of the fastest growing markets from 2002-2010. However, the market growth is expected to slow down in the future due to various restraints, such as the expiry of key drug patents across all disease segments, generic substitution, biosimilar penetration, and the decreasing annual cost of disease treatment in major markets such as the US, Japan and the top five countries in Europe. Nevertheless, the global coagulation disorders market is still forecast to grow at a moderate rate over the next seven years.
Read more inside Coagulation Disorders Market to 2017
Companies Mentioned:
- Baxter International Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- CSL Behring LLC
- Bayer AG
- LFB
- Grifols
- Biotest
- Bio Product Laboratory
- Octapharma
For more information visit http://www.researchandmarkets.com/research/20d8bb/coagulation_disord